loadpatents
name:-0.052772998809814
name:-0.020655155181885
name:-0.00052309036254883
Muto; Susumu Patent Filings

Muto; Susumu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Muto; Susumu.The latest application filed is for "peptide synthesis method".

Company Profile
0.16.38
  • Muto; Susumu - Kanagawa JP
  • Muto; Susumu - Tokyo N/A JP
  • Muto; Susumu - Bunkyo-ku JP
  • Muto; Susumu - Machida JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Peptide synthesis method
Grant 11,420,997 - Suzuki , et al. August 23, 2
2022-08-23
Peptide synthesis method
Grant 11,098,078 - Kono , et al. August 24, 2
2021-08-24
Peptide Synthesis Method
App 20210139532 - SUZUKI; Hideaki ;   et al.
2021-05-13
Peptide Synthesis Method
App 20180215782 - KONO; Yusuke ;   et al.
2018-08-02
PAI-1 inhibitor
Grant 8,633,245 - Yamaguchi , et al. January 21, 2
2014-01-21
Inhibitors against the production and release of inflammatory cytokines
Grant 8,263,657 - Muto , et al. September 11, 2
2012-09-11
Inflammatory cytokine release inhibitor
Grant 8,097,759 - Muto , et al. January 17, 2
2012-01-17
Derivative having PPAR agonistic activity
Grant 8,097,610 - Itai , et al. January 17, 2
2012-01-17
Oxazolidinone Derivative Having Inhibitory Activity On 11beta-hydroxysteroid Dehydrogenase Type 1
App 20110294813 - Itai; Akiko ;   et al.
2011-12-01
Carboxilic acid derivatives
Grant 8,044,236 - Yamaguchi , et al. October 25, 2
2011-10-25
Oxazolidinone derivative having inhibitory activity on 11.beta.-hydroxysteroid dehydrogenase type 1
Grant 7,998,992 - Itai , et al. August 16, 2
2011-08-16
N-phenyloxamide derivatives
Grant 7,884,234 - Yamaguchi , et al. February 8, 2
2011-02-08
Inflammatory Cytokine Release Inhibitor
App 20100274051 - MUTO; Susumu ;   et al.
2010-10-28
Heterocyclic Derivative Having Inhibitory Activity On Type-i 11 Data-hydroxysteroid Dehydrogenase
App 20100234363 - Itai; Akiko ;   et al.
2010-09-16
Oxazolidinone Derivative Having Inhibitory Activity On 11beta-hydroxysteroid Dehydrogenase Type 1
App 20100113448 - Itai; Akiko ;   et al.
2010-05-06
O-substituted Hydroxyaryl Derivatives
App 20100113770 - MUTO; Susumu ;   et al.
2010-05-06
Antiallergic agents
Grant 7,700,655 - Muto , et al. April 20, 2
2010-04-20
N-(3,4-disubstituted phenyl) salicylamide derivatives
Grant 7,671,058 - Tokuyama , et al. March 2, 2
2010-03-02
Pai-1 Inhibitor
App 20090312315 - Yamaguchi; Youichi ;   et al.
2009-12-17
O-substituted hydroxyaryl derivatives
Grant 7,626,042 - Muto , et al. December 1, 2
2009-12-01
Derivative having ppar agonistic activity
App 20090286974 - Itai; Akiko ;   et al.
2009-11-19
Amide derivatives
Grant 7,598,418 - Muto , et al. October 6, 2
2009-10-06
Inhibitor Of Pai-1 Production
App 20090239868 - Muto; Susumu ;   et al.
2009-09-24
N-Phenyloxamide derivatives
App 20090215899 - YAMAGUCHI; Youichi ;   et al.
2009-08-27
Inflammatory Cytokine Release Inhibitor
App 20090192122 - MUTO; Susumu ;   et al.
2009-07-30
Sulfonamide derivatives
Grant 7,547,716 - Muto , et al. June 16, 2
2009-06-16
Inflammatory Cytokine Release Inhibitor
App 20080318956 - MUTO; Susumu ;   et al.
2008-12-25
Inhibitors against activation of NF-kappaB
App 20080311074 - MUTO; Susumu ;   et al.
2008-12-18
Carboxilic acid derivatives
App 20080275116 - YAMAGUCHI; Youichi ;   et al.
2008-11-06
Inflammatory Cytokine Release Inhibitor
App 20080249071 - MUTO; Susumu ;   et al.
2008-10-09
N-Phenyloxamide derivatives
App 20080249175 - YAMAGUCHI; Youichi ;   et al.
2008-10-09
Medicament For Treatment Of Neurodegenerative Diseases
App 20080234233 - MUTO; Susumu ;   et al.
2008-09-25
N-(3,4-disubstituted phenyl) salicylamide derivatives
App 20080227784 - TOKUYAMA; Ryukou ;   et al.
2008-09-18
Coumarin derivative
Grant 7,411,076 - Muto , et al. August 12, 2
2008-08-12
Antiallergic Agents
App 20080090779 - Muto; Susumu ;   et al.
2008-04-17
Plasminogen Activator Inhibitor-1 Inhibitor
App 20070276011 - Muto; Susumu ;   et al.
2007-11-29
Medicament for Therapeutic and/or Preventive Treatment of Restenosis or Reocclusion After Vascular Recanalization Operation
App 20070254956 - Shudo; Koichi ;   et al.
2007-11-01
Antiallergic agents
App 20070185059 - Muto; Susumu ;   et al.
2007-08-09
Antiallergic agents
App 20070185110 - Muto; Susumu ;   et al.
2007-08-09
Medicament for treatment of dermal pigmentation
App 20070042997 - Itai; Akiko ;   et al.
2007-02-22
Quinazolin-4-one derivatives
App 20060229324 - Itai; Akiko ;   et al.
2006-10-12
Antiallergic
App 20060122243 - Muto; Susumu ;   et al.
2006-06-08
Medicament for treatment of diabetes
App 20060111409 - Muto; Susumu ;   et al.
2006-05-25
Inhibitors against the activation of ap-1 and nfat
App 20060100257 - Muto; Susumu ;   et al.
2006-05-11
O-substituted hydroxyaryl derivatives
App 20060094718 - Muto; Susumu ;   et al.
2006-05-04
Nf-kb activation inhibitors
App 20060089395 - Muto; Susumu ;   et al.
2006-04-27
Remedies for neurodegenerative diseases
App 20060035944 - Muto; Susumu ;   et al.
2006-02-16
Immunity-related protein kinase inhibitors
App 20060019958 - Muto; Susumu ;   et al.
2006-01-26
Medicament for treatment of cancer
App 20060014811 - Muto; Susumu ;   et al.
2006-01-19
Amide derivatives
App 20050215645 - Muto, Susumu ;   et al.
2005-09-29
Coumarin derivative
App 20050054717 - Muto, Susumu ;   et al.
2005-03-10
Inhibitors against the production and release of inflammatory cytokines
App 20040259877 - Muto, Susumu ;   et al.
2004-12-23
Sulfonamide derivatives
App 20040234622 - Muto, Susumu ;   et al.
2004-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed